FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Trading Up 3.9% – Should You Buy?

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was up 3.9% during mid-day trading on Friday . The stock traded as high as $41.37 and last traded at $43.31. Approximately 12,299 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 41,663 shares. The stock had previously closed at $41.66.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Performance

The stock has a market cap of $356.41 million, a P/E ratio of 24.90 and a beta of 0.37. The company’s 50 day moving average price is $42.42 and its 200-day moving average price is $40.44.

Institutional Trading of FT Vest U.S. Equity Deep Buffer ETF – October

Several institutional investors have recently made changes to their positions in DOCT. NBC Securities Inc. boosted its holdings in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 94,640.0% in the 1st quarter. NBC Securities Inc. now owns 4,737 shares of the company’s stock worth $181,000 after buying an additional 4,732 shares during the last quarter. Farther Finance Advisors LLC purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF – October in the 1st quarter worth about $554,000. Lcnb Corp boosted its holdings in shares of FT Vest U.S. Equity Deep Buffer ETF – October by 0.5% in the 1st quarter. Lcnb Corp now owns 114,284 shares of the company’s stock worth $4,383,000 after buying an additional 607 shares during the last quarter. OLD Mission Capital LLC purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF – October in the 1st quarter worth about $454,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in shares of FT Vest U.S. Equity Deep Buffer ETF – October in the 2nd quarter worth about $69,000.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.